Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
17.79
+0.35 (2.01%)
At close: Jun 26, 2026, 4:00 PM EDT
17.85
+0.06 (0.34%)
After-hours: Jun 26, 2026, 7:43 PM EDT
Amylyx Pharmaceuticals Employees
Amylyx Pharmaceuticals had 136 employees as of December 31, 2025. The number of employees increased by 13 or 10.57% compared to the previous year.
Employees
136
Change (1Y)
13
Growth (1Y)
10.57%
Revenue / Employee
n/a
Profits / Employee
-$1,103,765
Market Cap
1.98B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Perrigo Company | 8,100 |
| Trulieve Cannabis | 5,000 |
| Phibro Animal Health | 2,475 |
| HUTCHMED (China) | 1,796 |
| ANI Pharmaceuticals | 970 |
| Prestige Consumer Healthcare | 890 |
| Supernus Pharmaceuticals | 778 |
AMLX News
- 2 days ago - Amylyx price target raised to $40, named a Best Idea at Guggenheim - TheFly
- 4 days ago - Amylyx to present data from first-in-human, dose-ranging Phase 1 Lumina trial - TheFly
- 4 days ago - Amylyx Pharmaceuticals to Present Data from First-in-Human, Dose-Ranging Phase 1 LUMINA Trial of AMX0114 in ALS at ENCALS 2026 - Business Wire
- 17 days ago - Amylyx Pharmaceuticals Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 19 days ago - Amylyx Pharmaceuticals Announces Poster Presentations at ENDO 2026 - Business Wire
- 23 days ago - Amylyx Pharmaceuticals Transcript: AGM 2026 - Transcripts
- 6 weeks ago - Amylyx announces publication of Phase 2 open-label HELIOS trial data - TheFly
- 6 weeks ago - Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label HELIOS Trial Data for AMX0035 in The Journal of Clinical Investigation - Business Wire